Header and Body 4

Advantages

  • Anti-metastasis drug candidates
  • Promising in vitro and in vivo pre-clinical data indicating effective metastasis inhibition
  • No toxicity at effective doses in vitro or in vivo
  • Potentially generalizable to other cancer types in addition to breast cancer